Patents by Inventor David Matthes
David Matthes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20080312158Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: ApplicationFiled: June 14, 2007Publication date: December 18, 2008Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Publication number: 20070033669Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: ApplicationFiled: October 12, 2006Publication date: February 8, 2007Applicant: The Regents of the University of CaliforniaInventors: Corey Goodman, Alex Kolodkin, David Matthes, David Bentley, Timothy O'Connor
-
Patent number: 7153936Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: February 4, 2002Date of Patent: December 26, 2006Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Publication number: 20030166849Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: ApplicationFiled: February 4, 2002Publication date: September 4, 2003Inventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Patent number: 6344544Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: April 15, 1998Date of Patent: February 5, 2002Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Patent number: 6013781Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: April 8, 1997Date of Patent: January 11, 2000Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Patent number: 5935865Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: April 15, 1998Date of Patent: August 10, 1999Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Patent number: 5807826Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: April 8, 1997Date of Patent: September 15, 1998Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor
-
Patent number: 5639856Abstract: A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.Type: GrantFiled: September 13, 1993Date of Patent: June 17, 1997Assignee: The Regents of the University of CaliforniaInventors: Corey S. Goodman, Alex L. Kolodkin, David Matthes, David R. Bentley, Timothy O'Connor